Van Der Poel H - Search Results

1

The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.

Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT). Tosco L, et al. Among authors: van der poel h, van den broeck t, van poppel h. Eur Urol Focus. 2018 Apr;4(3):369-375. doi: 10.1016/j.euf.2016.12.008. Epub 2017 Jan 17. Eur Urol Focus. 2018. PMID: 28753838 Clinical Trial.

2

Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.

van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: van stratum p. Urology. 1996 Sep;48(3):357-64. doi: 10.1016/S0090-4295(96)00210-5. Urology. 1996. PMID: 8804485 Free article. Clinical Trial.

3

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

4

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: van balken mr. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

5

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: van der poel hg. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

6

Recurrence of germ cell tumor after orchiectomy.

van der Poel HG, Sedelaar JP, Debruyne FM, Witjes JA. van der Poel HG, et al. Urology. 2000 Sep 1;56(3):467-73. doi: 10.1016/s0090-4295(00)00693-2. Urology. 2000. PMID: 10962317

7

Consecutive quantitative cytology in bladder cancer.

van der Poel HG, van Rhijn BW, Peelen P, Debruyne FM, Boon ME, Schalken JA. van der Poel HG, et al. Among authors: van rhijn bw. Urology. 2000 Oct 1;56(4):584-8. doi: 10.1016/s0090-4295(00)00726-3. Urology. 2000. PMID: 11018610

8

Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.

Spermon JR, Roeleveld TA, van der Poel HG, Hulsbergen-van de Kaa CA, Ten Bokkel Huinink WW, van de Vijver M, Witjes JA, Horenblas S. Spermon JR, et al. Among authors: van der poel hg, van de vijver m. Urology. 2002 Jun;59(6):923-9. doi: 10.1016/s0090-4295(02)01528-5. Urology. 2002. PMID: 12031382

9

Upper urinary tract cancer: location is correlated with prognosis.

van der Poel HG, Antonini N, van Tinteren H, Horenblas S. van der Poel HG, et al. Among authors: van tinteren h. Eur Urol. 2005 Sep;48(3):438-44. doi: 10.1016/j.eururo.2005.03.009. Epub 2005 Mar 29. Eur Urol. 2005. PMID: 16115524

10

Perineal salvage prostatectomy for radiation resistant prostate cancer.

van der Poel HG, Beetsma DB, van Boven H, Horenblas S. van der Poel HG, et al. Among authors: van boven h. Eur Urol. 2007 Jun;51(6):1565-71; discussion 1572. doi: 10.1016/j.eururo.2006.08.011. Epub 2006 Aug 24. Eur Urol. 2007. PMID: 16949728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page